NeurogesX, Inc. (NGSX) Posts Q3 Loss of 43c/Share
Tweet
Share
E-mailGet Alerts NGSX Hot Sheet
Price: $0.01 --0%
Financial Fact:
Research and development: 1.33M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 1.33M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
NeurogesX, Inc. (NASDAQ: NGSX) reported Q3 loss of ($0.43), $0.01 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $2.89 million versus the consensus estimate of $3.14 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
